中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Intestinal Transport and Biotransformation of Resibufogenin and Cinobufagin in Chan Su via HPLC/APCI-MS(n)

文献类型:期刊论文

作者Han TJ ; Wang Q ; Song FR ; Liu ZY ; Liu ZQ ; Liu SY
刊名chemical research in chinese universities
出版日期2011
卷号27期号:3页码:380-384
关键词CELL-SUSPENSION CULTURES CYTOTOXIC BUFADIENOLIDES PLATYCODON-GRANDIFLORUM LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY ABSORPTION MONOLAYERS PRODUCTS BUFALIN
ISSN号1005-9040
通讯作者liu zq
中文摘要in vitro models of human colon carcinoma cell line(caco-2 cell monolayer) and human intestinal bacteria were used to investigate the intestinal transport and biotransformation of resibufogenin and cinobufagin in chan su by hplc/apci-ms(n). the experimental results of caco-2 cell monolayer demonstrate that the apparent permeability coefficients(p(app)) of resibufogenin and cinobufagin are higher than 10(-6) cm/s, which indicates that both resibufogenin and cinobufagin have a good absorption in the small intestine. and the biotransformation result of human intestinal bacteria shows that resibufogenin has been transformed to 3-epiresibufogenin and cinobufagin has been transformed to 3-epicinobufagin, deacetylcinobufagin and 3-epideacetycinobufagin, respectively.
收录类别SCI收录期刊论文
语种英语
公开日期2012-06-11
源URL[http://ir.ciac.jl.cn/handle/322003/44657]  
专题长春应用化学研究所_长春应用化学研究所知识产出_期刊论文
推荐引用方式
GB/T 7714
Han TJ,Wang Q,Song FR,et al. Intestinal Transport and Biotransformation of Resibufogenin and Cinobufagin in Chan Su via HPLC/APCI-MS(n)[J]. chemical research in chinese universities,2011,27(3):380-384.
APA Han TJ,Wang Q,Song FR,Liu ZY,Liu ZQ,&Liu SY.(2011).Intestinal Transport and Biotransformation of Resibufogenin and Cinobufagin in Chan Su via HPLC/APCI-MS(n).chemical research in chinese universities,27(3),380-384.
MLA Han TJ,et al."Intestinal Transport and Biotransformation of Resibufogenin and Cinobufagin in Chan Su via HPLC/APCI-MS(n)".chemical research in chinese universities 27.3(2011):380-384.

入库方式: OAI收割

来源:长春应用化学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。